Factor VIII inhibitors.
- Published in:
- Haemophilia, 1995, v. 1, n. S2, p. 14, doi. 10.1111/j.1365-2516.1995.tb00117.x
- By:
- Publication type:
- Article
Works matching IS 13518216 AND DT 1995 AND VI 1 AND IP S2
Results: 10
1
2
The purification of factor VIII and the characterization of the human factor VIII gene.
- Published in:
- Haemophilia, 1995, v. 1, n. S2, p. 3, doi. 10.1111/j.1365-2516.1995.tb00112.x
- By:
- Publication type:
- Article
3
Prophylaxis versus purse strings: is safety an issue?
- Published in:
- Haemophilia, 1995, v. 1, n. S2, p. 24, doi. 10.1111/j.1365-2516.1995.tb00119.x
- By:
- Publication type:
- Article
4
The epidemiology of HIV disease in men with haemophilia in the UK.
- Published in:
- Haemophilia, 1995, v. 1, n. S2, p. 6, doi. 10.1111/j.1365-2516.1995.tb00114.x
- By:
- Publication type:
- Article
5
Future perspectives in paediatric haemophilia.
- Published in:
- Haemophilia, 1995, v. 1, n. S2, p. 12, doi. 10.1111/j.1365-2516.1995.tb00116.x
- By:
- Publication type:
- Article
6
Introduction.
- Published in:
- Haemophilia, 1995, v. 1, n. S2, p. 1, doi. 10.1111/j.1365-2516.1995.tb00111.x
- Publication type:
- Article
7
Virus safety considerations for recombinant factor VIII (rFVIII, Kogenate).
- Published in:
- Haemophilia, 1995, v. 1, n. S2, p. 22, doi. 10.1111/j.1365-2516.1995.tb00118.x
- By:
- Publication type:
- Article
8
Clinical development of recombinant factor VIII (rFVIII, Kogenate).
- Published in:
- Haemophilia, 1995, v. 1, n. S2, p. 26, doi. 10.1111/j.1365-2516.1995.tb00120.x
- By:
- Publication type:
- Article
9
Haemophilia in the UK: past, present and future.
- Published in:
- Haemophilia, 1995, v. 1, n. S2, p. 4, doi. 10.1111/j.1365-2516.1995.tb00113.x
- By:
- Publication type:
- Article
10
Immune function in patients receiving recombinant factor VIII (rFVIII, Kogenate) and other very-high-purity factor VIII products.
- Published in:
- Haemophilia, 1995, v. 1, n. S2, p. 8, doi. 10.1111/j.1365-2516.1995.tb00115.x
- By:
- Publication type:
- Article